Factors associated with low adherence to medicine treatment for chronic diseases in brazil

Página do item simplificado
dc.contributor.authorLeao Tavares, Noemia Urruth
dc.contributor.authorBertoldi, Andres Damaso
dc.contributor.authorMengue, Sotero Serrate
dc.contributor.authorDourado Arrais, Paulo Sergio
dc.contributor.authorLuiza, Vera Lucia
dc.contributor.authorOliveira, Maria Auxiliadora
dc.contributor.authorRamos, Luiz Roberto [UNIFESP]
dc.contributor.authorFarias, Mareni Rocha
dc.contributor.authorDal Pizzol, Tatiane da Silva
dc.date.accessioned2019-01-21T10:29:36Z
dc.date.available2019-01-21T10:29:36Z
dc.date.issued2016
dc.description.abstractOBJECTIVE: To analyze factors associated with low adherence to drug treatment for chronic diseases in Brazil. METHODS: Analysis of data from Pesquisa Nacional sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - Brazilian Survey on Access, Use and Promotion of Rational Use of Medicines), a population-based cross-sectional household survey, based on a probabilistic sample of the Brazilian population. We analyzed the association between low adherence to drug treatment measured by the Brief Medication Questionnaire and demographic, socioeconomic, health, care and prescription factors. We used Poisson regression model to estimate crude and adjusted prevalence ratios, their respective 95% confidence interval (95% CI) and p-value (Wald test). RESULTS: The prevalence of low adherence to drug treatment for chronic diseases was 30.8% (95% CI 28.8-33.0). The highest prevalence of low adherence was associated with individuals: young adultsen
dc.description.abstractno educationen
dc.description.abstractresident in the Northeast and Midwest Regions of Brazilen
dc.description.abstractpaying part of the treatmenten
dc.description.abstractpoor self-perceived healthen
dc.description.abstractthree or more diseasesen
dc.description.abstractreported limitations caused by a chronic diseaseen
dc.description.abstractusing five drugs or more. CONCLUSIONS: Low adherence to drug treatment for chronic diseases in Brazil is relevant, and regional and demographic differences and those related to patients' health care and therapy regime require coordinated action between health professionals, researchers, managers and policy makers.en
dc.description.affiliationDepartamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliationDepartamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliationPrograma de Pós-Graduação em Epidemiologia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationDepartamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliationDepartamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliationDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliationDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliationDepartamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliationUnifespDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sourceWeb of Science
dc.description.sponsorshipDepartment of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.description.sponsorshipDepartment of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2011-31]
dc.description.sponsorshipIDSCTIE/MS: 25000.111834/2011-31
dc.format.extent10s
dc.identifierhttp://dx.doi.org/10.1590/s1518-8787.2016050006150
dc.identifier.citationRevista De Saude Publica. Sao paulo, v. 50, n. 2, p. 10s, 2016.
dc.identifier.doi10.1590/S1518-8787.2016050006150
dc.identifier.fileS0034-89102016000300307.pdf
dc.identifier.issn0034-8910
dc.identifier.scieloS0034-89102016000300307
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/49283
dc.identifier.wosWOS:000391447400007
dc.language.isoeng
dc.publisherIop Publishing Ltd
dc.relation.ispartofRevista De Saude Publica
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMedication Adherenceen
dc.subjectPrimary-Careen
dc.subjectHypertensionen
dc.subjectNonadherenceen
dc.subjectMetaanalysisen
dc.subjectFrequencyen
dc.titleFactors associated with low adherence to medicine treatment for chronic diseases in brazilen
dc.titleFatores associados à baixa adesão ao tratamento farmacológico de doenças crônicas no Brasilpt
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos